{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:37:47Z","timestamp":1788435467698,"version":"build-2803163510"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nodular dermatitis (PN) is a severely itchy chronic skin disease with symmetrically distributed nodules, often linked to an atopic background in some patients. However, the pathogenesis of PN with atopic dermatitis remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The objective of this study is to compare the transcriptomes from skin biopsies of prurigo patients with and without atopic dermatitis, aiming to identify unique gene expression patterns and gain insights into the molecular mechanisms underlying Atopic dermatitis Prurigo (ADP) and Non-Atopic dermatitis Prurigo (NADP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We conducted transcriptome analysis to compare gene expression between normal controls and atopic dermatitis patients, identifying DEGs and performing KEGG and GO analyses, along with correlations between disease severity and itch NRS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We performed transcriptome profiling on 5 patients with ADP, 6 patients with NADP, and 6 healthy controls. Gene expression analysis revealed significant differences in inflammatory cytokines, suggesting that cytokine-mediated pathways play an important role in the pathogenesis of ADP. GO and KEGG analyses revealed cytokine-cytokine receptor interactions, with Th2 cytokines (SERPINB4, IL4R, IL24) upregulated in ADP and structural repair (BMP2) and metabolic genes (LEPR) elevated in NADP. Severity analysis showed positive correlations with SERPINB4, S100A8, IL24, and TGFB1, and negative correlations with BMP2, IL33, and LEPR. Keratinocyte hyperproliferation and inflammatory genes were commonly upregulated in both ADP and NADP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These results provide insight into the molecular mechanisms of PN, particularly in the context of atopic dermatitis, and highlight that immune dysregulation and impaired skin barrier function are key factors in pathogenesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1572413","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:27:24Z","timestamp":1762324044000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Transcriptomic analysis of skin biopsies in Prurigo nodularis patients: with and without atopic dermatitis"],"prefix":"10.3389","volume":"16","author":[{"given":"So Yeon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Young","family":"Um","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Bi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Woo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Suk","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Young","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Wook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye One","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.183","article-title":"Prurigo nodularis: Epidemiology and clinical features","volume":"83","author":"Huang","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-020-02148-0","article-title":"The impact of prurigo nodularis on quality of life: a systematic review and meta-analysis","volume":"313","author":"Janmohamed","year":"2021","journal-title":"Arch Dermatol Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.05.036","article-title":"Health-related quality of life and economic burden of prurigo nodularis","volume":"86","author":"Whang","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-023-00999-9","article-title":"Validation of the peak pruritus numerical rating scale as a patient-reported outcome measure in prurigo nodularis","volume":"13","author":"Kwatra","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B5","article-title":"FDA approves first treatment for\u00a0prurigo nodularis","year":"2022"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.jid.2021.02.749","article-title":"Prurigo nodularis is characterized by systemic and cutaneous T helper 22 immune polarization","volume":"141","author":"Belzberg","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.10.004","article-title":"Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab","volume":"149","author":"Tsoi","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000517","article-title":"Effectiveness of dupilumab for the treatment of generalized prurigo nodularis phenotype of adult atopic dermatitis","volume":"31","author":"Napolitano","year":"2020","journal-title":"Dermatitis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/exd.14678","article-title":"RNA sequencing reveals the transcriptome profile of the atopic prurigo nodularis with severe itching","volume":"32","author":"Shao","year":"2023","journal-title":"Exp Dermatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.12.018","article-title":"Atopic dermatitis is an IL-13-dominant disease with greater molecular heterogeneity compared to psoriasis","volume":"139","author":"Tsoi","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"8098","DOI":"10.1038\/s41598-024-58013-x","article-title":"Comprehensive plasma cytokine and chemokine profiling in prurigo nodularis reveals endotypes in Type 2 inflammation","volume":"14","author":"Cornman","year":"2024","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.02.038","article-title":"Long-term dupilumab treatment for chronic refractory generalized prurigo nodularis: A retrospective cohort study","volume":"85","author":"Georgakopoulos","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.05.029","article-title":"Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb","volume":"143","author":"Wollenberg","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.0079","article-title":"Efficacy and safety of lebrikizumab, a high-affinity interleukin 13 inhibitor, in adults with moderate to severe atopic dermatitis: A phase 2b randomized clinical trial","volume":"156","author":"Guttman-Yassky","year":"2020","journal-title":"JAMA Dermatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.02.010","article-title":"Cutaneous transcriptomics identifies fibroproliferative and neurovascular gene dysregulation in prurigo nodularis compared with psoriasis and atopic dermatitis","volume":"142","author":"Sutaria","year":"2022","journal-title":"J\u00a0Invest Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1600-0625.2006.00504.x","article-title":"Early cutaneous gene transcription changes in adult atopic dermatitis and potential clinical implications","volume":"16","author":"Plager","year":"2007","journal-title":"Exp Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2023.05.011","article-title":"Single-cell transcriptomic analysis of prurigo nodularis skin reveals T-cell\u2013driven inflammation and therapeutic targets","volume":"143","author":"Calugareanu","year":"2023","journal-title":"J Invest Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10498.x","article-title":"Nuclear localization of activated STAT6 and STAT3 in epidermis of prurigo nodularis","volume":"165","author":"Fukushi","year":"2011","journal-title":"Br J Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14570","article-title":"European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo","volume":"32","author":"Pereira","year":"2018","journal-title":"J Eur Acad Dermatol Venereology: JEADV"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501647","article-title":"Control of the physical and antimicrobial skin barrier by an IL-31-IL-1 signaling network","volume":"196","author":"H\u00e4nel","year":"2016","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jid.2019.08.438","article-title":"IL-17A Induces Endothelin-1 Expression through p38 Pathway in Prurigo Nodularis","volume":"140","author":"Wong","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1038\/s41467-022-30089-x","article-title":"Neuronal pentraxin 2 is required for facilitating excitatory synaptic inputs onto spinal neurons involved in pruriceptive transmission in a model of chronic itch","volume":"13","author":"Kanehisa","year":"2022","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1533033819869928","DOI":"10.1177\/1533033819869928","article-title":"Overexpression of FNDC1 relates to poor prognosis and its knockdown impairs cell invasion and migration in gastric cancer","volume":"18","author":"Liu","year":"2019","journal-title":"Technol Cancer Res Treat"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.03.935","article-title":"Molecular signature of pruriceptive mrgprA3(+) neurons","volume":"140","author":"Xing","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"101967","DOI":"10.1016\/j.mcp.2024.101967","article-title":"LncRNA lnc-SPRR2G-2 contributes to keratinocyte hyperproliferation and inflammation in psoriasis by activating the STAT3 pathway and downregulating KHSRP","volume":"76","author":"Zhen","year":"2024","journal-title":"Mol Cell Probes"},{"key":"B26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2199-13-20","article-title":"SPRR2A enhances p53 deacetylation through HDAC1 and down regulates p21 promoter activity","volume":"13","author":"Mizuguchi","year":"2012","journal-title":"BMC Mol Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"9243","DOI":"10.3390\/ijms21239243","article-title":"Prolidase stimulates proliferation and migration through activation of the PI3K\/akt\/mTOR signaling pathway in human keratinocytes","volume":"21","author":"Misiura","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/procel\/pwae030","article-title":"IL-24 promotes atopic dermatitis-like inflammation through driving MRSA-induced allergic responses","volume":"16","author":"Qian","year":"2024","journal-title":"Protein Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/ijms19041102","article-title":"Squamous cell carcinoma antigen 2 (SCCA2, SERPINB4): an emerging biomarker for skin inflammatory diseases","volume":"19","author":"Izuhara","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.224626","article-title":"Murine insulin growth factor-like (IGFL) and human IGFL1 proteins are induced in inflammatory skin conditions and bind to a novel tumor necrosis factor receptor family member, IGFLR1","volume":"286","author":"Lobito","year":"2011","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1038744","article-title":"Applications of single-cell RNA sequencing in atopic dermatitis and psoriasis","volume":"13","author":"Xia","year":"2022","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.04.019","article-title":"Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis","volume":"152","author":"Alkon","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5164","DOI":"10.3390\/ijms25105164","article-title":"Prurigo nodularis: pathogenesis and the horizon of potential therapeutics","volume":"25","author":"Yook","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.01.042","article-title":"Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis","volume":"145","author":"He","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2010.01089.x","article-title":"Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity\u2013a tale of conflict and conundrum","volume":"36","author":"M\u00fcller","year":"2010","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1016\/j.jid.2022.02.014","article-title":"BMPR1a is required for the optimal TGF\u03b21-dependent CD207(+) langerhans cell differentiation and limits skin inflammation through CD11c(+) cells","volume":"142","author":"Hochgerner","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.jaci.2020.09.038","article-title":"Bone morphogenetic protein signaling regulates skin inflammation via modulating dendritic cell function","volume":"147","author":"Sconocchia","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23168911","article-title":"(EDA) signaling: from skin appendage to multiple diseases","volume":"23","author":"Yang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12026-012-8283-9","article-title":"IL-33\/ST2 axis in inflammation and immunopathology","volume":"52","author":"Milovanovic","year":"2012","journal-title":"Immunol Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1476-9255-8-22","article-title":"Role of IL-33 in inflammation and disease","volume":"8","author":"Miller","year":"2011","journal-title":"J Inflammation (London England)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00364","article-title":"IL33: roles in allergic inflammation and therapeutic perspectives","volume":"10","author":"Chan","year":"2019","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1186\/s12967-023-04782-4","article-title":"Role of IL-33-ST2 pathway in regulating inflammation: current evidence and future perspectives","volume":"21","author":"Zhou","year":"2023","journal-title":"J Transl Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12967-024-04972-8","article-title":"Senescent fibroblast facilitates re-epithelization and collagen deposition in radiation-induced skin injury through IL-33-mediated macrophage polarization","volume":"22","author":"Chen","year":"2024","journal-title":"J Transl Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2017.06.249","article-title":"IL-33 improves wound healing through enhanced M2 macrophage polarization in diabetic mice","volume":"90","author":"He","year":"2017","journal-title":"Mol Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"100205","DOI":"10.1016\/j.xjidi.2023.100205","article-title":"Nuclear IL-33 plays an important role in EGFR-mediated keratinocyte migration by regulating the activation of signal transducer and activator of transcription 3 and NF-\u03baB","volume":"3","author":"Dai","year":"2023","journal-title":"JID Innov"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.787713","article-title":"IL-33 and the PKA pathway regulate ILC2 populations expressing IL-9 and ST2","volume":"13","author":"Olgu\u00edn-Mart\u00ednez","year":"2022","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200829","article-title":"Cutting edge: CCR8 signaling regulates IL-25- and IL-33-responsive skin group 2 innate lymphoid cell migration and function","volume":"211","author":"Sun","year":"2023","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00631-2","article-title":"\u03b3\u03b4 T cells, Tregs and epithelial cells interact with IL-33 in the lung","volume":"18","author":"Darrigues","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00475","article-title":"The ST2\/IL-33 axis in immune cells during\u00a0inflammatory diseases","volume":"8","author":"Griesenauer","year":"2017","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16266","article-title":"IL-33 drives the production of mouse regulatory T cells with enhanced in vivo suppressive activity in skin transplantation","volume":"21","author":"Kawai","year":"2021","journal-title":"Am J Transplant"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113242","article-title":"Mast cell cytokines in acute and chronic gingival tissue inflammation: role of IL-33 and IL-37","volume":"23","author":"Trimarchi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41598-017-00840-2","article-title":"Interleukin-33 regulates intestinal inflammation by modulating macrophages in inflammatory bowel disease","volume":"7","author":"Seo","year":"2017","journal-title":"Sci Rep"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1097\/00006534-199801000-00003","article-title":"Bone morphogenetic protein-2 induces scar formation and skin maturation in the second trimester fetus","volume":"101","author":"Stelnicki","year":"1998","journal-title":"Plast Reconstr Surg"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1572413\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:27:25Z","timestamp":1762324045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1572413\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2025.1572413"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1572413","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"article-number":"1572413"}}